EcoDrugPlus

Ensembl ID : ENSHHUG00000017208
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSHHUG00000017274
Gene Symbol: -
Cross references: -
140 Possible Orthologues:

Ensembl ID : ENSHHUG00000041874
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSHHUG00000005632
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSHHUG00000042361
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSHHUG00000017392
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSHHUG00000041986
Gene Symbol: RPL19
1 Cross references
345 Possible Orthologues:

Ensembl ID : ENSHHUG00000030653
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSHHUG00000040055
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSHHUG00000042752
Gene Symbol: -
Cross references: -
128 Possible Orthologues:

Ensembl ID : ENSHHUG00000039940
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSHHUG00000018791
Gene Symbol: -
Cross references: -
27 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).